Orally Disintegrating Tablets That Can Be Taken Without Water

Jeil Pharmaceutical announced on the 23rd the launch of 'Jeprammeltz Orally Disintegrating Tablets (active ingredient Escitalopram Oxalate),' a depression treatment in the form of orally disintegrating tablets that can be taken without water.


Jeil Pharmaceutical's depression treatment drug, Zephrameltz. <br>[Photo by Jeil Pharmaceutical]

Jeil Pharmaceutical's depression treatment drug, Zephrameltz.
[Photo by Jeil Pharmaceutical]

View original image

Jeprammeltz Orally Disintegrating Tablets contain the same active ingredient as Jepram tablets and were developed to improve medication adherence for patients who have difficulty taking oral medications, such as the elderly and those with swallowing disorders. Orally disintegrating tablets dissolve quickly in the mouth without water, making them useful for patients who have difficulty swallowing pills or have restrictions on fluid intake.


Jeprammeltz Orally Disintegrating Tablets come in three dosages: 5 mg, 10 mg, and 20 mg, allowing dosage adjustment according to the patient's symptoms starting from a low dose. An orange flavor familiar to patients was added to enhance medication adherence.


According to academic data from A Delini-Stula, a study on the preference for antidepressant orally disintegrating tablets and medication adherence involving 5,428 patients showed that 62.1% preferred orally disintegrating tablets, and 47.3% of patients experienced improved medication adherence. Jeil Pharmaceutical explained that this indicates that the orally disintegrating tablet formulation can be a treatment option that enhances medication adherence and improves treatment rates for patients with depression.



Jang Woo-jin, Marketing PM at Jeil Pharmaceutical, said, "As the number of depression patients in Korea increases to about one million, interest in treatments is also rising," adding, "We will continue to strive to provide patients with new formulation treatment options so they can lead healthy lives."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing